2019
DOI: 10.1016/j.ymgme.2018.12.200
|View full text |Cite
|
Sign up to set email alerts
|

Enzyme replacement therapy together with renin-angiotensin system inhibition seems to prevent kidney function decrease in most Finnish Fabry patients treated either for 5 or 10 years

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles